Clinical Trial Update: A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating dupilumab in adults and adolescents with eosinophilic gastritis with or without eosinophilic duodenitis (EGID), and the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Duodenitis
• Eosinophilic Gastritis
• Eosinophilic Gastroenteritis
• Eosinophilic Gastrointestinal Disease

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING